Drug-Resistant Mycobacterium tuberculosis Isolates from New and Previously Treated TB Patients in China, 2017-2019
Rev. Soc. Bras. Med. Trop
; Rev. Soc. Bras. Med. Trop;54: e0728-2020, 2021. tab, graf
Article
em En
| LILACS
| ID: biblio-1155535
Biblioteca responsável:
BR1.1
ABSTRACT
Abstract INTRODUCTION:
Mycobacterium tuberculosis (MTB) is a causative agent of tuberculosis (TB) that causes death worldwide.METHODS:
MTB was subjected to phenotypic drug-susceptibility tests (DST), and drug-resistant genes were sequenced.RESULTS:
Previously treated patients were more likely to have positive smear results and exhibit drug resistance. New patients were more likely to be mono SM-resistant and less likely to be INH- and RIF-resistant. The most common mutations were katG (S315T), rpoB (S450L), rpsL (K43R), and embB (M306V).CONCLUSIONS:
The proportion of mono-SM-resistant TB among new patients was higher.Assuntos
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
LILACS
Assunto principal:
Preparações Farmacêuticas
/
Tuberculose Resistente a Múltiplos Medicamentos
/
Mycobacterium tuberculosis
Limite:
Humans
País/Região como assunto:
Asia
Idioma:
En
Revista:
Rev. Soc. Bras. Med. Trop
Assunto da revista:
MEDICINA TROPICAL
Ano de publicação:
2021
Tipo de documento:
Article
País de afiliação:
China
País de publicação:
Brasil